关于“Nectin-4 定向抗体药物偶联物恩福妥昔单抗治疗相关皮肤事件的管理”。
Regarding "Management of Dermatologic Events Associated with the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin".
机构信息
Dermatology Department, Henri Mondor Hospital, AP-HP, Univ Paris-est Créteil EpidermE, Créteil, France.
Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions (TOXIBUL), Créteil, France.
出版信息
Oncologist. 2022 Oct 1;27(10):e825-e826. doi: 10.1093/oncolo/oyac170.
Abstract
This letter to the editor remarks on a recently published article about dermatologic events induced by enfortumab vedotin, comparing results from other similar studies.
摘要
这封给编辑的信评论了最近发表的一篇关于恩福妥滨引起的皮肤科事件的文章，比较了其他类似研究的结果。
Zotero 插件